During the past decade, Virologie - Hôpital Paul Brousse conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Virologie - Hôpital Paul Brousse" are "Cytomegalovirus" (1 trials) and "Transplant Recipients With CMV Infection" (1 trials). Many other conditions were trialed in "Virologie - Hôpital Paul Brousse" in a lesser frequency.

Most popular intervention types in "Virologie - Hôpital Paul Brousse" are "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "CMV Infection" (1 trials) and "depistage" (1 trials). Other intervention names were less common.

The vast majority of trials in "Virologie - Hôpital Paul Brousse" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Virologie - Hôpital Paul Brousse". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Virologie - Hôpital Paul Brousse, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Virologie - Hôpital Paul Brousse, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".